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Edited by Gianni CesareniAbstract Adducin regulates tubular absorption of sodium by
modulating the expression levels of the sodium–potassium-ATP-
ase in renal tubular cells. Adducin is a candidate gene in the
pathogenesis of hypertension. Yeast two hybrid screen showed
a speciﬁc interaction between human alpha Adducin and the reg-
ulatory factor for X box (RFX-1), a nuclear protein that down
regulates the expression of several proteins in non neuronal cells.
The interaction was conﬁrmed in cells through coimmunoprecip-
itation and colocalization experiments. The binding of alpha
Adducin to RFX-I and their nuclear co-localization suggests that
Adducin can have a role in modulating the transcriptional regu-
lating activity of RFX-I.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Essential hypertension is a multifactorial disease due to ge-
netic and environmental factors. It is a common disease with
a prevalence ranging from 25% to 30%, with wide variations
depending on the ethnical and racial composition of the pop-
ulation [1].
Recent studies suggest that Adducin plays a leading role in
the pathogenesis of human hypertension. Mutations in the al-
pha-Adducin gene have been associated with increased renal
sodium retention and with the development of high blood
pressure in humans and rodents [2,3], although this associa-
tion has not been found in all the populations studied [4,5].
Alpha Adducin is an ubiquitously expressed cytoskeleton
protein that is involved in cell-to-cell contact [6] and regulates
both actin dynamics [7] and the expression of the sodium–
potassium-ATPase on the basolateral side of renal tubular*Corresponding author. Fax: +3909613694090.
E-mail address: perrotti@unicz.it (N. Perrotti).
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doi:10.1016/j.febslet.2005.10.040cells, thus modulating the complex tubular re-absorption of
sodium. The activity of the sodium–potassium-ATPase pump
is regulated by hormonal factors, like dopamine, aldosterone
and vasopressin as well as by non hormonal factors. The so-
dium retentive eﬀect has been attributed to an increase in the
rate of actin polymerization and in the number of Na, K-
ATPase units in the plasma membrane of renal tubular cells
[8].
We performed yeast two hybrid screening using a kidney li-
brary as a source of prey cDNA. A clone coding for a putative
Adducin interactive molecule was identiﬁed, as the COOH ter-
minal sequence of regulatory factor for X box (RFX-I), a non
neuronal cell-speciﬁc transcription factor that inactivates the
transcription of the microtubule-associated protein MAP1A
[9].
We present evidence, based upon colocalization and coim-
munoprecipitation experiments, that the interaction is speciﬁc
and occurs in yeast as well as in eukaryotic cells. These ﬁndings
suggest that Adducin can have a role in modulating the tran-
scriptional regulating activity of RFX-I, with possible conse-
quences on the establishment of an actin-microtubule
cytoskeleton network, regulating the internalization of Na,
K-ATPase subunits.2. Materials and methods
2.1. Constructs
pCMVneoHA-Adducin. The full length human Adducin cDNA,
cloned into pCMVneoHA, was a generous gift of Prof. Bianchi.
pBridge-Adducin. Polymerase chain reaction (Klen.Taq; BD Biosci-
ences/Clontech, Palo Alto, CA) was used to amplify alpha Adducin
from pCMVneoHA-Adducin. Primers introducing EcoRI restriction
site (CAGAATTCATGAATG GTGATTCTCGTGCTG) and BamHI
restriction site (CTGGATCCTCAGGAGTCACTCTTCT) were used.
The ampliﬁed fragment, ﬂanked by an EcoRI site upstream and a
BamHI site downstream, was ligated into pGEM-T Easy vector (Pro-
mega, Madison, WI, USA) and subcloned into the multiple cloning
sites of pBridge (Clontech laboratories, Inc. Palo Alto, CA ).
pCDNA3 Myc-RFX-I. A pCMV SPORT 6 vector containing the full
length cDNA sequence of RFX1 was obtained from Research Genetics
through Invitrogen (Invitrogen, Carlsbad, CA).
The coding sequence of RFX-I was ampliﬁed from pCMV SPORT 6
RFX-1 by a PCR based method (Klen.Taq).ation of European Biochemical Societies.
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(1) (ATGCGGAATTCCATGGAACAAAAACTCATCTCAGAC-
GAGGATCTGGCAACACAGGCG TAT) introduced an
EcoRI restriction site and a Myc tag 5 0 to the sequence coding
for RFX-1.
(2) (GGCACTCGAG TTAGCTGGAGGGCAGCGCCT) intro-
duced a XhoI site 3 0 to the sequence coding for RFX-1.
The ampliﬁed fragment, was subcloned into pcDNA3 (Invitrogen).
This vector was used in all the experiments requiring the expression
of RFX-1 in eukaryotic cells.
2.2. Yeast two hybrid screening
To identify Adducin binding proteins, a yeast two hybrid system was
used (MATCHMAKER Gal4 Two-Hybrid Clontech Laboratories
Inc.) [10]. The bait plasmid pBridge-Adducin, with full length human
alpha Adducin expressed as a fusion protein with the DNA binding
domain (BD) of the yeast transcription factor Gal 4, was used to trans-
form a suitable yeast strain (Saccharomyces cerevisae AH109). The
yeasts transformed by pBridge-Adducin were used for mating with a
Saccharomices cerevisiae host strain Y187 (Clontech laboratories,
Inc.) pretransformed by a MATCHMAKER human Kidney cDNA
pACT2 derived library, cloned into a yeast GAL4 activation domain
(AD) expressing proteins containing a HA-tag at the N terminus. After
20 h of mating we spread the mating mixture on SD/-Ade/-His/-Leu/-
Trp plates. Yeast colonies that demonstrated activation of both report-
ers conferring galactose-dependent blue staining in the presence of
X-Gal (5-bromo-4chloro-3-indolylbeta-D-galactopyranoside) and ade-
nine and histidine-independent growth were selected and considered
for further evaluation to screen for putative alpha Adducin interacting
proteins.
Library plasmid DNA was isolated from this selection of clones in
presence of lyticase solution and then rescued into HB101 Escherichia
coli strain by the CaCl2 method (Invitrogen.). The transformants were
recovered on minimal M9 selective medium lacking leucine for nutri-
tional selection. The speciﬁcity of the interaction was tested for several
clones by retransforming the interactor plasmid into yeast expressing
pBridge-Adducin bait, as well as in yeast strain transformed with
empty vector, pBridge and two unrelated bait plasmids: pBridge-
HMG and pBridge-SGK. The growth was then assayed on plates
SD/-Ade/-His/-Leu/-Trp. The cDNA encoding speciﬁc alpha Adducin
interacting proteins were sequenced and studied with BLAST analysis.2.3. Expression in COS 7
COS 7 cells were plated at a density of 3.5 · 105 cells/ml in six well
plates. For the immunoﬂuorescence studies cells were plated at a den-
sity of 2.0 · 105 cells/ml on glass cover slips in individual 35 mm plates.
Cells were cultured overnight in DMEM containing 10% fetal bovine
serum (Invitrogen). The following day the cells were transfected with
eukaryotic expression vectors using lipofectamine plus (Invitrogen.)Fig. 1. Identiﬁcation of regulatory factor for box X-I (RFX-I) as Adducin int
cotrasformed with p-Bridge-Add and pACT2-RFX-I were able to grow in sel
interaction was speciﬁc because yeasts cotransformed by vectors expressi
HMG(Y) and p-Bridge empty vector, were unable to grow in selective medifollowing the manufacturers instructions. We used pCMVneoHA-
Adducin (600 ng/ml) and pCDNA3 Myc-RFX-1 (600 ng/well) for the
coimmunoprecipitation experiments and for the confocal microscopy
experiments. Empty vectors were transfected in the sham transfected
cells.
Five hours after transfecting the cells, the transfection medium was
changed with DMEM medium containing fetal bovine serum (10%)
and antibiotics (penicillin, 100 U/ml, and streptomycin, 100 lg/ml).
Thirty-six hours after transfection, the cells were used for studying
the coimmunoprecipitation and the colocalization experiments. Confo-
cal microscopy experiments showed that the eﬃciency of transfection
reached approximately 30%.2.4. Coimmunoprecipitation experiments
The transfected cells were solubilized for 20 min, at 4 C, in a solu-
bilization buﬀer (250 ll/well) containing: 25 mM Hepes, 100 mM KCl,
12.5 mM MgCl2, 0.1 mM EDTA, 10% glycerol, 0.1%, Nonidet P-40,
pH 7.9, with protease inhibitors complete TM (Roche Molecular Bio-
chemicals, Mannheim, Germany) and phosphatase inhibitors (100 mM
NaF; 5 mM sodium pyrophosphate; 2 mM sodium orthovanadate,
5 mM EDTA). Protein extracts were quantiﬁed by means of a Brad-
ford based assay (Bio-Rad, Hercules, CA), and an aliquot (20lg) of
protein extracts was analyzed by immunoblotting with rabbit anti-
HA (Roche Diagnostic) and rabbit anti-Myc (Santa Cruz Biotechnol-
ogy, CA) to assess the expression of HA-Adducin and Myc-RFX-1.
Four hundred micrograms of proteins were immunoprecipitated with
mouse anti-HA antibodies, (8 ll, Roche Diagnostic S.p.A., Italy) at
4 C, overnight. The antibody was bound to protein G-Ultralink
(15 ml, Pierce) at 4 C for 60 min. The immune complexes were sedi-
mented, washed three times with a washing buﬀer containing 25 mM
Hepes, 100 mM KCl, 12.5 mM MgCl2, 0.1 mM EDTA, 10% glycerol,
0.1%, Nonidet P-40, pH 7.9 [4]. The pellets were then resuspended in
Laemmli sample buﬀer containing dithiothreitol (1 mM), boiled for
5 min, and separated by SDS polyacrylamide gel electrophoresis using
a 10% gel. The proteins were transferred to nitrocellulose, blocked in
5% non fat dry milk in TTBS and incubated with rabbit anti-HA anti-
body at a dilution of 1:1000 in 5% non fat dry milk in TTBS, to detect
immunoprecipitated Adducin, rabbit anti Myc antibody at a dilution
of 1:1000 in 5% non fat dry milk in TTBS for the detection of RFX-1.2.5. Immunoﬂuorescence for Adducin, RFX-1 and spekles SC-35
For the immunoﬂuorescence experiments, cells were plated and
transfected with the appropriate vectors. After 24 h of incubation
with the transfection mixture, the cells were ﬁxed with 4% formalde-
hyde in PBS at 4 C for 15 min and then permeabilized with 0.5%
Triton X-100 in PBS. In the Adducin/RFX-1 colocalization experi-
ments Adducin was visualized with a mouse anti-HA antibody (Santa
Cruz Biotechnology Inc.). In the Adducin/speckles sc-35 colocaliza-
tion experiments Adducin was visualized with rabbit anti HAeracting protein using yeast two-hybrid assay. AH 109 yeast strain cells
ective medium lacking histidine, tryptophan, leucine, and adenine. The
ng diﬀerent molecules, pACT2-RFX-I with p-Bridge SgK, pBridge
um.
R. Boito et al. / FEBS Letters 579 (2005) 6439–6443 6441antibodies (Santa Cruz). RFX-1 was visualized with a rabbit anti-
Myc antibody (Santa Cruz). sc-35 speckles were visualized with a
mouse monoclonal anti sc-35 antibody (Sigma–Aldrich, Milan, Italy).
All the primary antibodies were diluted 1:200 in Blocking solution
(BSA 1%, Triton 0.1% in PBS). Adducin was detected, with 1:800
Alexa Fluor 568 goat anti mouse IgG (Molecular Probes) in the
Adducin/RFX-1 colocalization experiments, and with 1:800 Alexa
Fluor 488 goat anti rabbit IgG (Molecular Probes) in the Adducin/
speckles sc-35 colocalization experiments. RFX-1 was detected with
1:800 Alexa Fluor 488 goat anti rabbit IgG (Molecular Probes). sc-
35 speckles were detected with 1:800 Alexa Fluor 568 goat anti
mouse IgG (Molecular Probes). All the incubations were performed
in a humidiﬁed chamber. After being washed with PBS, cells were
mounted in Prolong anti fade reagent (Molecular Probes) and visual-
ized using a confocal microscope (Leica Microsystems, Wetzlar,
Germany).Fig. 2. Panel A, B and C. Coimmunoprecipitation on Adducin and
RFX-1. COS-7 cells were transfected with empty vector (panels A, B,
C, lane 1), pCMVneoHA Adducin (panels A, B, C, lane 3),
pcDNA3Myc RFX-1 (panels A, B, lanes 2, 3, panel C lanes 2, 3,
and 4 as a control). Rabbit anti Myc and anti HA immunoglobulins
allowed the detection of HA-alpha Adducin (panel A lane 3) and Myc
RFX-1 (panel A, lanes 2 and 3) in cell extracts. Mouse anti HA
immunoglobulins were used to immunoprecipitate HA-Adducin,
detected by blotting with rabbit anti HA antibodies, as expected
(panel B, lane 3). RFX-1 was detected by blotting with HA rabbit anti
Myc antibodies (panel C, lane 3), only in HA immunoprecipitates from
cells transfected with vectors coding for HA Adducin and Myc RFX-1,
thus proving that the interaction between alpha Adducin and RFX-1
occurs in eukaryotic cells. Lane 4 shows the Myc RFX-1 detected with
rabbit anti Myc antibodies in extracts from cells transfected with
pCMVneoMyc RFX-1.3. Results
3.1. Yeast two-hybrid screening reveals speciﬁc Adducin/RFX-1
interaction
Two hybrid screening allowed us the identiﬁcation of dif-
ferent independent clones, interacting speciﬁcally with Addu-
cin. Approximately, 10 million yeast transformants were
screened. We found only one putative interacting clone.
Blast analysis of the corresponding cDNA revealed that
the library clone contained a partial sequence coding for
the COOH terminal region, from Leucine 866 to the end
of the molecule, of the regulatory factor for X box (RFX-
I) (Fig. 1). The interaction was speciﬁc since the growth
on plates SD/-Ade/-His/-Leu/-Trp was observed only when
the interactor plasmid pACT2-RFX-1 was retransformed
into yeast expressing pBridge-Adducin bait. No growth
was observed when the interactor plasmid pACT2-RFX-1
was retransformed into yeast containing the empty vector
pBridge or two unrelated bait plasmid: pBridge-HMG(Y)
and pBridge-PTPg (Fig. 1).
3.2. Coimmunoprecipitation of Adducin and RFX-1 in COS-7
cells
Rabbit anti Myc and anti HA immunoglobulins allowed the
detection of HA-alpha Adducin (Fig. 2 panel A, lanes 3) and
Myc-RFX-1 (Fig. 2 panel A, lanes 2 and 3) in cell extracts.
Mouse anti HA immunoglobulins were used to immunoprecip-
itate HA-Adducin, detected by blotting with rabbit anti HA
antibodies as expected (Fig. 2 panel B, lanes 3). RFX-1 was
detected, by blotting with a rabbit anti Myc antibody (Fig. 2
panel C, lane 3), only in HA immunoprecipitates from cells
transfected with vectors coding for HA Adducin and Myc
RFX-1, thus proving that the interaction between alpha Addu-
cin and RFX-1 occurs in eukaryotic cells. As positive control
Myc-RFX-1 was detected by rabbit Myc antibodies in extracts
from cells transfected with pCDN3- Myc RFX-1 (Fig. 2 panel
C, lane 4).3.3. Adducin colocalizes with RFX-1 in speciﬁc subnuclear
domains
The localization of alpha Adducin, RFX-1 was studied in
COS7 cells by confocal microscopy (Fig. 3 panels A and B).
Both the proteins localized in subnuclear structures, similar
to the subnuclear domains, previously described as typical of
RFX-1. Colocalization of alpha Adducin and RFX-1 was
demonstrated by the appearance of the yellow color in the al-pha Adducin, RFX-1 overlay (Fig. 3, panel A). Interestingly,
alpha Adducin showed no colocalization with other subnu-
clear structures (speckles) identiﬁed by the mouse sc-35 anti-
body in separate experiments, thus conﬁrming the speciﬁcity
of the subnuclear colocalization between alpha Adducin and
RFX-1 (Fig. 3, panel B).4. Discussion
The understanding of the mechanisms underlying renal
tubular sodium reabsorption is very important in enlightening
the genetic mechanisms of human hypertension. Alpha-Addu-
cin is a cytoskeleton protein [11] involved in the complex renal
Fig. 3. Panels A and B. Colocalization of alpha Adducin and RFX1 in
COS7 cells (panel A) and immunoﬂuorescence of Adducin-S-35 by
confocal microscopy (panel B). COS 7 cells grown on glass coverslips
at 50% conﬂuence were transfected with expression vectors encoding
the full-length Ha-tagged Adducin (pCMVneo-Ha-Adducin) and the
full-length Myc-tagged RFX-I (pcDNA3-Myc-RFX-I). Serum-starved
cells were ﬁxed as indicated in Section 2. Panel A: HA-Adducin was
detected by mouse anti-HA antibodies and visualized by anti mouse
antibody (ALEXA FLUOR 568 goat anti-mouse IgG-) (panel A, a1),
Myc RFX-1 was detected by rabbit anti-Myc antibodies and visualized
by ALEXA FLUOR 488 goat anti-rabbit Ig G (panel A, b1). Panel B:
HA-Adducin was detected by rabbit anti HA antibodies and visualized
by ALEXA FLUOR 488 goat anti-rabbit Ig G (panel B, a2). The Sc-
35, detected by mouse anti-Sc-35 antibodies and visualized by Alexia
Fluor 568 goat anti-mouseIgG] (panel B, b2). Images shown in c1 and
c2 represent the overlay of a1 and b1, a2 and b2, respectively.
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levels of the sodium–potassium-ATPase on the basolateral side
of renal tubular cells [8].
In the present paper, we present evidences of structural
interaction between alpha Adducin and a regulatory factor
X-I box (RFX-I), a non neuronal cell-speciﬁc transcription
factor that inactivates the transcription of the microtubule-
associated protein MAP 1A [9]. The interaction was ﬁrst
discovered in yeast, and then conﬁrmed in eukaryotic cells.
Interestingly alpha-Adducin colocalized with RFX-1 in spe-
ciﬁc subnuclear structures, as previously described for RFX-
1 [12]. On the contrary a very weak, if any colocalization at
all, was found between alpha Adducin and other transcrip-
tionally active subnuclear structures, named speckles [13].
The activity of RFX-I as a transcription factor is regulatedin a complex manner. RFX-I belongs to a protein family
sharing a DNA-binding domain and a conserved C-terminal
region. In RFX-I, the C terminal region mediates the dimer-
ization, and is followed by a terminal tail, containing a highly
acidic stretch. The adjacent ‘‘acidic region’’ potentiates the
functions of the NLS such as the nuclear import and DNA-
binding activity of RFX-1. In HL-60 cells nuclear transloca-
tion of RFX-1 is regulated by protein Kinase C through a
poorly characterized mechanism [12]. RFX-1 has been shown
to be able to bind to regulatory elements of several genes. It
associates with a Myc intron binding factor (MIBP1) to acti-
vate myc expression [14] as well as with a B cell speciﬁc activ-
ity protein (BSAP/Pax5) that regulates B spell speciﬁcity of
Epstein Barr virus growth transforming function [15]. RFX-
1 also interacts with and activates cAbl kinase, a non receptor
tyrosine kinase activated in the nucleus during S phase [16].
RFX-1 homodimers, RFX-1/RFX-2 heterodimers and RFX5
can form complexes on methylated as well as unmethylated
collagen transcription factor start site, thereby controlling col-
lagen expression [17]. This activity can explain some of RFX1
function in the light of the mechanisms of inﬂammation were
INFc decreases and TGFb increases collagen transcription.
Moreover a RFX1 transcription factor binding site has been
located in the promoter region of the gene coding for 11b-
hydroxysteroid dehydrogenase, type 2 (11bHSD2) [18], thus
suggesting that RFX1 can indeed modulate the expression of
an enzyme involved in regulating the sodium retentive activity
of steroids. On the other hand, a gene transcription regulating
activity has recently been described for nuclear actin-binding
proteins [19].
Although a functional meaning of the interaction described
in the present paper is still lacking, the binding of alpha Addu-
cin to RFX-1 and their speciﬁc nuclear co-localization strongly
suggests that Adducin can have a role in modulating the tran-
scription regulating activity of RFX-1. Interestingly adducin
colocalizes with RFX-1, a negative regulator of the transcrip-
tion of speciﬁc genes, not with the proteins identiﬁed by the
sc-35 anti speckles antibody, which detects transcriptionally
active subnuclear domains [20]. Taken together these data
suggest that alpha adducin can be involved in modulating
the negative regulation of transcription through RFX-1.
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